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UNIT A1.2Rule Out (R/O) Intracranial Aneurysm
When imaging patients for intracranial aneurysm, the goals are: (1) to assess the contour
of the intracranial arteries, particularly in the regions of the ACOM (anterior communi-
cating artery), PCOM (posterior communicating artery), ICA (internal carotid artery)
bifurcation, MCA (middle cerebral artery) trifurcation, basilar tip, and PICA (posterior
inferior cerebellar artery); (2) to assess the anatomy of the Circle of Willis and direction
of flow, and; (3) to determine if there is evidence of a recent subarachnoid bleed. The 3-D
time-of-flight (TOF) magnetic resonance angiography (MRA) is used for assessing
contour and anatomy of the major intracranial arteries. The 2-D phase contrast (PC)
sequence is used to determine the direction of flow. A fluid-attenuated inversion recovery
(FLAIR) sequence is used to search for evidence of a recent subarachnoid bleed. If
vasospasm is a clinical concern, diffusion- and perfusion-weighted imaging are added to
the imaging assessment. The following Basic Protocol can be used for the evaluation of
stable patients, and requires 20 min, 18 sec to complete.
BASIC
PROTOCOL
STANDARD IMAGING FOR ANEURYSM DETECTION
In order to perform the optional sequences for perfusion and diffusion studies, a scanner
with echo-planar capabilities is required (Table A1.2.1). MR angiography and the standard
anatomical MR imaging sequences included in the protocol do not require these faster
gradients. The parameters given here are optimized for a 1.5T General Electric (GE) LX
system with software version 8.35 and may require modification if using different
software versions, field strengths, or manufacturers.
Data processing is required for the 3-D TOF MRA sequence described in this protocol.
For optimal assessment of the volumetric 3-D TOF MRA data, separate volumes of
interest (VOI) for the left anterior, right anterior, and posterior circulation should be
created. Images from 15°-rotations about the vertical axis should be saved. An additional
anterior circulation volume of interest should include both anterior cerebral arteries and
the region of the anterior communicating artery for visual inspection. Images from
15°-rotations about the horizontal axis should also be saved. Although maximum intensity
projections (MIP) are superior to volume and surface reconstructions for assessment of
vascular patency, surface reconstructions can be helpful in visualizing aneurysms. All of
our MRA data are processed on a GE Advantage Windows Workstation version 3.1P using
standard GE Advantage Windows software or FuncTool version 1.9M. In the hands of an
experienced technologist, the postprocessing will require ∼5 min.
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as crash carts or oxygen.
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Table A1.2.1 Equipment Requirements for Cerebral Vascular
Assessment
Coil type Quadrature head or neurovascular coil
Gradient coil strength 22 mT/m (or whatever the system permits)
Slew rate ≥120 T/m/sec
Cardiac gating Not necessary
Peripheral gating Not necessary
Respirator If required by patient
Oxygen If required by patient
Motion cushions Useful




Set up patient and equipment
1. Interview (screen) the patient to ensure that he or she has no counterindications such
as cardiac pacemakers or other implants containing ferromagnetic materials. Also be
sure to find out if the patient has any health conditions that may require the presence
of special emergency equipment during the scanning procedure, or necessitate any
other precautions. Do not forget to ask if the patient has any drug allergies and
document them.
Generally, standard screening forms are used for all patients scanned in a magnetic
resonance system (see APPENDIX 1).
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with any metal implants; see Shellock
(1996) for discussion of what implants may be safely scanned using magnetic resonance.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent
forms.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in clothing.
4. Have the patient wash off any mascara and other makeup to avoid local tissue heating
and image artifacts.
5. Inform the patient about what will occur during the procedure, what he or she will
experience while in the magnet, and how to behave, including the following:
a. If earphones or headphones are used to protect the ears from the loud sounds
produced by the gradients, the patient will be asked to wear these, but will be able
to communicate with you at any time during the imaging.
b. The patient will be given a safety squeeze-bulb or similar equipment to request
assistance at any time (demonstrate how this works).
c. For good results the patient should not talk, and should avoid or minimize
swallowing or other movement, during each scan—i.e., as long as the banging
sounds continue. Between scans, talking and swallowing are allowed in most
cases, but should be avoided when comparative positional studies are being
performed; the patient will be informed when this is the case.
d. Nevertheless, the patient may call out at any time if he or she feels that it is
necessary.
6. Have the patient mount onto the table. Either before or right after the patient lies
down, set up any triggering devices or other monitoring equipment that is to be used.
7. Center the patient in a head or neurovascular coil at the region where the key
information is desired. Make sure that the head and neck are constrained to prevent
motion, especially if high-resolution scans are to be run.
Generally, the patient’s head is fixed so that the head is horizontal (not tilted) and the neck
and head lie along the axis of the patient table; other positions may be appropriate
depending on the needs at hand.
Most scanners have a special neurovascular coil for MRA; otherwise, a head coil should
be used and the patient is placed as far in as possible so that the bifurcation of the main
carotid artery into the internal and external carotid arteries can be imaged.





Table A1.2.2 Rapid Sagittal T1-Weighted Scout
Patient position Supine
Scan type 2-D gradient echo
Imaging plane (orientation) Sagittal
Central slice or volume center Nasion
Echo time (TE) Minimum (at least 4.1 msec)
Receiver bandwidth (RBW) ±15.6 kHz
Repeat time (TR) 100 msec
Flip angle (FA) 60°
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (∆x, ∆y) 0.94 mm, 1.88 mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 7 mm
Number of slices 7
Slice gap 2 mm
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 1
Read direction Anterior–posterior
Scan time 16 sec
Table A1.2.3 Transverse FLAIR
Patient position Supine
Scan type Inversion recovery, fast-spin echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) 140 msec
Receiver bandwidth (RBW) ±20.83 kHz
Echo train length (ETL) 12 (not selectable on GE’s system)
Repeat time (TR) 10,000 msec
Inversion time (TI) 2200 msec
Flip angle (FA) 180°
Fields of view (FOVx, FOVy) 220 mm, 165 mm
Resolution (∆x, ∆y) 0.86 mm, 0.86 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 12
Slice gap 1
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 2
Read direction Anterior–posterior
Scan time 5 min, 20 sec




8. If needed, place a pillow or other support under the knees to make the patient more
comfortable.
9. Place the patient such that the laser light is centered over the patient’s nasion, and put
him or her into the center of the magnet.
Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
10. If the patient is unable to hold still, provide an appropriate sedative.
Sequence 1: Rapid sagittal T1-weighted scout
11. To validate the patient’s position, perform a fast sagittal scout scan using the imaging
parameters in Table A1.2.2. (Some medical centers may prefer a rapid three-plane
scout instead of this multi-slice sagittal scout.)
Table A1.2.4 Transverse 3-D TOF MRA
Patient position Supine
Scan type 3-D vascular TOF short TR gradient
echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) 3.2 msec
Receiver bandwidth (RBW) ±15.6 kHz
Repeat time (TR) 33 msec
Flip angle (FA) 20°
Fields of view (FOVx, FOVy) 220 mm, 165 mm
Resolution (∆x, ∆y) 0.86 mm, 0.86 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 1.4 mm
Number of slices per slab 32
Number of slabs 2
Slab overlap 4 slices
Slice gap 0 mm
Number of excitations (NEX) 1






Extended dynamic range (EDR) Yes
Magnetization transfer Yes
Vascular options Reprojections = 19°
Collapse = on
Ramp pulse = inferior to superior
Scan time 6 min, 32 sec





Sequence 2: Transverse FLAIR
12. From the sagittal scout, select the image through the center of the brain to set up the
locations for the transverse FLAIR sequence. The locations should be the same as
those chosen for the transverse diffusion sequence (if it will be run at a latter time).
Set up the imaging parameters according to Table A1.2.3.
13. Warn the patient that this sequence is starting and begin the scan.
Sequence 3: Transverse 3-D TOF MRA
14. From the sagittal scout, select the image through the center of the brain to set up the
locations for the transverse 3-D TOF MRA. Set up the imaging parameters according
to Table A1.2.4.
Two slabs are posted on the midline sagittal image, centered at the top of the sella tursica.
15. Warn the patient that this sequence is starting and begin the scan.
Data processing and viewing for sequence 3
16. Once the transverse partitions from the 3-D TOF MRA have been obtained, select
three volumes of interest (VOI) that select out the posterior circulation, the right
anterior circulation and the left anterior circulation, and rotate the maximum intensity
projections or surface reconstructions of these three VOIs through 360° about the
vertical axis, saving images at 15°-intervals. Rotate a fourth VOI, that selects out both
anterior circulations, through 360° about the horizontal axis, saving images at
15°-intervals.
Table A1.2.5 Transverse 2-D Phase Contrast
Patient position Supine
Scan type 2-D vascular phase contrast gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Nasion
Echo time (TE) 6 msec
Repeat time (TR) 20 msec
Flip angle (FA) 20°
Fields of view (FOVx, FOVy) 220 mm, 165 mm
Resolution (∆x, ∆y) 0.86 mm, 1.29 mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 10 mm
Number of slices 3
Slice gap 0 mm
Number of excitations (NEX) 4




Vascular options Flow reconstruction type = phase difference
Velocity encoding = 80 cm/sec
Acquired flow directions = all
Collapse = on
Flow analysis = off
Additional flow images = R/L, A/P, S/I, MAG
Scan time 1 min, 33 sec




Sequence 4 (optional): Transverse 2-D phase contrast
Flow direction information may be helpful in determining which vessels contribute flow
to the aneurysm.
17. From the sagittal scout, select the image through the center of the brain to set up the
locations for the transverse 2-D PC MRA. Set up the imaging parameters according
to Table A1.2.5.
Three slices are posted on the midline sagittal image, centered at the top of the sella tursica.
18. Warn the patient that this sequence is starting and begin the scan.
Sequence 5: Transverse T2-weighted fast-spin echo (FSE)
19. From the sagittal scout, select the image through the center of the brain to set up the
locations for the transverse T2-weighted FSE sequence. The locations should be the
same as those chosen for the transverse diffusion sequence (if it will be used). Set up
the imaging parameters according to Table A1.2.6.
20. Warn the patient that this sequence is starting and begin the scan.
Table A1.2.6 Transverse T2-Weighted FSE
Patient position Supine
Scan type Fast-spin echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Pulse sequence database (PSD) FSE-XL
Central slice or volume center Nasion
Echo time (TE) 102 msec
Receiver bandwidth (RBW) ±11.36 kHz
Echo train length (ETL) 12
Repeat time (TR) 6000 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 220 mm, 165 mm
Resolution (∆x, ∆y) 0.86 mm, 0.86 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 28
Slice gap 1 mm
Number of excitations (NEX) 2
Number of acquisitions (Nacq) 1
Read direction Anterior–posterior
Flow compensation Yes
Extended dynamic range (EDR) Yes
Scan time 2 min, 48 sec







ANEURYSM SCREEN AND ASSESSMENT FOR VASOSPASM/INFARCTION
When there is concern for vasospasm and infarction, the imaging sequences in the Basic
Protocol should be performed with the addition of the diffusion and perfusion sequences
described below.
Materials
Normal saline (0.9% NaCl), sterile
Gadolinim-DTPA contrast agent (e.g., Magnevist, Omniscan, or Prohance)
Set up equipment and patient
1. Repeat Basic Protocol, steps 1 to 5.
2. Establish an intravenous (i.v.) line from which the contrast agent can be injected, and
attach this line securely to the patient so that movement into or out of the magnet will
not pull at the patient’s arm.
It is preferable to insert the line prior to imaging and to leave the patient in the magnet,
with no intervening motion, between the scans run before contrast agent injection and those
run after injection.
3. Connect the MR compatible injection pump that is cleared of air and loaded with a
double dose of contrast agent and with saline flush, to the patient. Do a small test
injection to ensure that the i.v. is working properly.
4. Program the 5 ml/sec injection rate for both contrast agent and saline, contrast agent
dose required (double dose by weight), saline flush required (typically 40 ml) and
10-sec time delay. Start the saline running to keep the vein open, and arm the injection
pump. Do not inject the contrast agent at this time.
5. Repeat Basic Protocol, steps 6 to 10.
Sequences 1 to 5
6. Perform sequences 1 to 5 as described in the Basic Protocol.
Sequence 6: Transverse diffusion
7. From the sagittal scout, select the image through the center of the brain to set up the
locations for the transverse diffusion-weighted sequence. The transverse images
should begin at the foramen magnum and end at the top of the brain. Set up imaging
parameters according to Table A1.2.7.
8. Warn the patient that this sequence results in loud beeping noises and begin the scan.
Data processing and viewing for sequence 6
9. Process the diffusion-weighted images.
Most diffusion-weighted sequences will perform a minimum of four sequences: three with
orthogonal diffusion gradient directions and one with a minimal or no diffusion gradient.
Often, a fifth set of images is also provided that combines the three orthogonal gradient
images to produce a set of images whose signal intensity is not affected by the diffusion
direction. This is the diffusion-weighted trace image (DWI). In order to obtain Apparent
Diffusion Coefficient (ADC) maps the images may need further processing. On a GE
system, the ADC maps can be obtained by processing on the Advantage Window Worksta-
tion version 3.1P using FuncTool version 1.9M.




Table A1.2.7 Transverse Diffusion
Patient position Supine
Scan type Single-shot spin-echo-EPI (echo
planar imaging), diffusion
Imaging plane (orientation) Transverse
Pulse sequence database (PSD) epi2NV
Central slice or volume center Nasion
Echo time (TE) 99.3 msec
Repeat time (TR) 6000 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 220 mm, 220 mm
Resolution (∆x, ∆y) 1.72 mm, 1.72 mm
Number of data points collected (Nx, Ny) 128, 128
Display matrix (Dx, Dy) 128, 128
Slice thickness (∆z) 5 mm
Number of slices 23
Slice gap 1 mm
Number of excitations (NEX) 3
Number of acquisitions (Nacq) 1
Read direction Right–left
Saturation pulses Fat saturation (automatic with EPI)
Control variables (CV) Ramp sampling = 1, burst sampling = 0
b-value 1000 sec/min2
Scan time 2 min, 38 sec
Table A1.2.8 Transverse Perfusion
Patient position Supine
Scan type Single-shot spin-echo-EPI
Pulse sequence database (PSD) epi2perf
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) 65 msec
Receiver bandwidth (RBW) ∼200 kHz (not selectable on GE’s system)
Repeat time (TR) 1500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 220 mm, 220 mm
Resolution (∆x, ∆y) 1.72 mm, 1.72 mm
Number of data points collected (Nx, Ny) 128, 128
Display matrix (Dx, Dy) 128, 128
Slice thickness (∆z) 5 or 6 mm
Number of slices 11
Slice gap 1 mm
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 1
Read direction Left–right
Slice location Inferior slice to include MCA
Multi-phase Yes, 46 phases per location, minimum delay
between acquisitions
Slice series Interleaved
Control variables (CV) Ramp sampling = on, burst sampling = off
Scan time 1 min, 11 sec





Sequence 7: Transverse perfusion
10. Using the transverse FSE T2-weighted images, find the slice location where the
middle cerebral arteries are best seen. Using the imaging parameters as shown in
Table A1.2.8, set up the transverse images starting at the same location as the MCA
were identified on the T2-weighted FSE images. Typically, only 10 or 11 slices can
be obtained in the given TR interval. The slice thickness and gap can be modified so
that the perfusion study covers any diffusion abnormality.
11. Check that the injection pump is ready to inject the contrast agent and that the
injection is set to start 10 sec after the scan begins.
12. Warn the patient that this sequence is starting and that part of the way through the
scan the iv injection will occur. Warn the patient that a cool sensation may be felt
during the injection. Begin the scan.
A dose of 0.2 mmol/kg (which is equivalent to two usual doses) of contrast agent is usually
given.
Data processing and viewing for sequence 7
13. Process the perfusion images on an Advantage Windows Workstation version 3.1P
using FuncTool version 1.9M to give maps of relative cerebral blood volume (rCBV),
relative cerebral blood flow (rCBF) and mean transit time (MTT).
COMMENTARY
Background Information
Subarachnoid hemorrhage (SAH) due to
rupture of intracranial aneurysms is a major
cause of cerebrovascular disease related death
(Whisnant et al., 1982; Ingall et al., 1989).
Between 1% and 7.9% of the population have
unruptured aneurysms (Locksley, 1969;
Rosenorn et al., 1988; Atkinson et al., 1989;
Ingall et al., 1989; Inagawa and Hirano, 1990;
Iwata et al., 1991; Nakagawa and Hashi, 1994;
Rinkel et al., 1998) with annual risks of rupture
estimated to be 0.5% (International Study of
Unruptured Intracranial Aneurysms Investiga-
tors, 1998) to 2.3% (Yasui et al., 1997). Mor-
tality rates with SAH have been reported to be
as high as 52% to 67% (Winn et al., 1977;
Whisnant et al., 1982; Juvela et al., 1993; Yasui
et al., 1997; International Study of Unruptured
Intracranial Aneurysms Investigators, 1998).
With the advent of MR (and computed to-
mography; CT) angiography, there has been
increasing interest in screening for the presence
of aneurysms, particularly in patients with
higher risks such as patients with polycystic
kidney disease, connective tissue disorders, or
two first-degree relatives with intracranial
aneurysms. The sensitivity of 3-D TOF MRA
at 1.5T for detecting aneurysms has been re-
ported to be 75% dropping to 58% for aneu-
rysms <5 mm (Korogi et al., 1997). When all
image sequences are closely scrutinized includ-
ing the 3-D TOF MRA partition data and MIP,
sensitivity has been reported to be 81% with
100% specificity in the setting of acute SAH
(Wilcock et al., 1996).
In most medical centers, MR (or CT)
angiography has replaced catheter angiography
in screening patients at risk for intracranial
aneurysms and to follow known aneurysms. In
patients with acute subarachnoid hemorrhage,
it can also be used prior to catheter angiography
to plan the optimal projections on catheter
angiography and to help visualize the surgical
approach. CT angiography is beginning to pro-
vide strong competition in this area, especially
for presurgical planning where bony landmarks
are often helpful to the surgeon.
With the location of aneurysms being most
common in the ACOM, MCA bifurcation,
PCOM, carotid siphon, basilar tip, and PICA
origin, these regions are the main target areas
for MR angiography. MR angiography is not
sensitive at detecting aneurysms in distal
branches and therefore if distal aneurysms,
such as mycotic aneurysms, are suspected,
catheter angiogram is still the study of choice.
FLAIR imaging is highly sensitive in the
detection of subarachnoid hemorrhage in the
acute stage (Fig. A1.2.1; Singer et al., 1998;
Bakshi et al., 1999) but artifacts from flowing
CSF (cerebrospinal fluid) that is not suppressed
may be difficult to differentiate from true
subarachnoid blood since both are hyperin-
tense. Some authors suggest using proton den-




sity–weighted images in conjunction with
FLAIR images to help differentiate flow arti-
facts from blood since all cases of subarachnoid
blood seen on CT were also seen on the proton
density–weighted sequence (Wiesmann et al.,
1999). The authors find correlation with the
T2-weighted FSE sequence helpful in distin-
guishing flow artifacts but still obtain noncon-
trast CT studies prior to MRI to rule out acute
SAH.
In patients with vasospasm, those that were
symptomatic showed areas of increased signal
on diffusion-weighted imaging consistent with
areas of acute ischemia. In these same patients,
perfusion-weighted imaging showed larger ar-
eas of increased transit time in a distribution
that correlated with clinical symptoms (Ror-
dorf, 1999). This study indicated that there was
a role for diffusion- and perfusion-weighted
imaging in the diagnosis and evaluation of
patients with symptomatic vasospasm.
Critical Parameters and
Troubleshooting
Important basic parameters in MR angiog-
raphy are discussed in UNIT A1.1. If the MIP
representations are difficult to interpret, surface
reconstructions may improve aneurysm visu-
alization. Also, multiplanar (including curved)
reformations may help in optimizing aneurysm
visualization, particularly visualization of the
aneurysm neck. If there is a large and/or par-
tially thrombosed aneurysm, a post contrast
3-D TOF MRA may be helpful. With the post-
contrast MRA, the TR can be decreased and the
flip angle increased compared to the pre-con-
trast study to improve visualization.
With FLAIR sequences, it is important to
make sure that the TR and T1 values have not
been modified and that vendor-specific recom-
mendations for optimal CSF suppression have
been followed. For example, in GE FLAIR
sequences, at least 2 interleaved acquisitions
are required for optimal CSF suppression.
Anticipated Results
The 3-D TOF MRA data should allow
accurate 3-D visualization of aneurysms >3
mm in size as well as visualization of the
aneurysm neck and relationship to other in-
tracranial structures (Fig. A1.2.2). When
MIPs are confusing, multiplanar reforma-
A B
Figure A1.2.1 Transverse FLAIR images at the level of the basal cisterns (A) and level of the basal ganglia
(B). Increased signal is seen throughout the subarachnoid spaces including the anterior interhemispheric
fissure, basal cisterns and bilateral sylvian fissures. High signal material is also seen layering in the posteriorly
in the trigones of lateral ventricles in (B). The high signal is due to acute subarachnoid and intraventricular
blood.





tions may be helpful to differentiate an in-
fundibulum from an aneurysm and may help in
the assessment of the aneurysm neck. Partially
thrombosed aneurysms may have regions of
intrinsically bright T1-weighted signal due to
methemaglobin but these can be distin-
guished from flow related enhancement by
viewing the partition data.
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A1.2.12
Rule Out (R/O)
Intracranial
Aneurysm
